29.08.2014 - An experimental Ebola vaccine from GlaxoSmithKline is being fast-tracked into clinical trials with human patients, and the company plans to immediately begin building a stockpile...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)